Ardelyx Obtains $60,200,000 New Round

  • Feed Type
  • Date
    6/19/2014
  • Company Name
    Ardelyx
  • Mailing Address
    34175 Ardenwood Blvd. Fremont, CA 94555 USA
  • Company Description
    Ardelyx (NASDAQ: ARDX) targets specific gut transporters and receptors with drugs that address important medical issues in cardiovascular disease, diabetes and chronic kidney disease.
  • Website
    http://www.ardelyx.com
  • Transaction Type
    IPO
  • Transaction Amount
    $60,200,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms